Verruca Vulgaris

12 registered clinical trials studyying Verruca Vulgaris.

Status	Trial	Sponsor	Phase
Terminated	Cold Atmospheric Plasma Device Extension Study NCT05937672	Medical University of South Carolina	Phase 3
Completed	Safety and Efficacy of VDMN-21 Patch in Subjects With Common Warts NCT05799157	Veradermics, Inc.	Phase 2
Unknown	Assessment of Squamous Cell Carcinoma antigen2 in Verruca Vulgaris NCT05409365	Sohag University	—
Completed	Cold Atmospheric Plasma Device for Pediatric Molluscum and Verruca NCT05070754	Medical University of South Carolina	Phase 4
Unknown	Photodynamic Therapy in Treatment of Verrucae NCT04620785	Alexandria University	N/A
Completed	Is Involucrin Has a Role in Verruca Vulgaris? A Clinical and Immunohistochemical Study NCT04793529	Benha University	N/A
Completed	Cantharidin and Occlusion in Verruca Epithelium NCT03487549	Verrica Pharmaceuticals Inc.	Phase 2
Completed	Exploratory Study of Efficacy and Safety of Ingenol Mebutate 0.05% Gel for Common Warts on the Hands. NCT02748902	Neal D. Bhatia, MD	Phase 1
Completed	ALC-919 For The Treatment Of Common Warts NCT02483455	Veloce BioPharma LLC	Phase 2
Terminated	Pulsed 1064nm Nd:YAG in the Treatment of Verruca Vulgaris Versus Conventional Therapy With Liquid Nitrogen Cry NCT01609530	Trinity Health Michigan	N/A
Completed	A Trial Examining the Treatment of Common Warts With Combination Liquid Nitrogen (LN2) and Cantharidin NCT01084824	North Idaho Dermatology	N/A
Completed	Clinical Trial Evaluating Efficacy of Duct Tape for Treatment of Warts NCT00328991	Minneapolis Veterans Affairs Medical Center	N/A